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Background: Eosinophilic esophagitis (EoE) is related to allergic diseases such as bronchial asthma (BA),
atopic dermatitis, and allergic rhinitis. The aim of this study was to examine the eosinophil inﬁltration in
the upper gastrointestinal (GI) tract in patients with BA using esophagogastroduodenoscopy.
Methods: Patients with BA who had upper GI tract symptoms were enrolled. Patients who received
systemically administered steroids were excluded. Eosinophil inﬁltrations in the esophagus, stomach,
and duodenum were examined with regard to the endoscopic ﬁndings and pathological ﬁndings of bi-
opsy specimens (UMIN000010132).
Results: Ninety patients were enrolled from October in 2012 to September in 2014. Thirty-six were male,
54 were female, and the mean age was 57.5 years. Eighty-one (90%) used inhaled corticosteroids.
Fourteen patients (15.6%) had reﬂux esophagitis, 8 of whom had grade A and 6 had grade B. No patient
with EoE was observed. One female patient who had marked eosinophil inﬁltration in the esophagus,
stomach, and duodenum was diagnosed as having eosinophilic gastroenteritis, but endoscopy showed
only mucosal edema in the antrum. Another female patient who had marked eosinophil inﬁltration in
the esophagus, stomach, and duodenum was diagnosed as having eosinophilic granulomatosis with
polyangiitis, and endoscopy showed erosions in the antrum and the duodenum. Three patients had
eosinophil inﬁltration in the stomach, but none of them had severe symptoms.
Conclusions: Patients with asthma who had upper gastrointestinal symptoms rarely had eosinophilic
gastrointestinal disorders. Biopsy specimens are of high importance in the diagnosis of eosinophilic
gastrointestinal disorders even if there is no remarkable endoscopic ﬁnding.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis
(EGE) are rare pathological conditions characterized by dense
inﬁltration of eosinophils in esophagogastrointestinal mucosa.1,2
When eosinophil inﬁltration is demonstrated only in the esopha-
geal epithelial layer, the pathological condition is called EoE. On the
other hand, when it is found in gastric and/or intestinal/colonicInternal Medicine, Saitama
, Iruma-gun, Saitama
).
ety of Allergology.
rgology. Production and hosting by Elsemucosa irrespective of esophageal involvement, it is called EGE.
Affected patients develop esophageal ﬁbrostenotic complications
after chronic inﬂammation and often suffer from dysphagia, swal-
lowing discomfort, and heartburn.3e5 Patients with EGE have
abdominal pain and diarrhea, high peripheral eosinophil counts,
and gastrointestinal wall thickening identiﬁable in CT images. The
prevalence of EoE has been reported to be increasing rapidly in
Western countries.6e9 Straumann et al.1 reported that in
Switzerland it increased from 2/100,000 in 1989 to 23/100,000 in
2004. Similarly, Prasad et al.9 found that in the US it was 55/100,000
in 2006 and that the incidence of clinically diagnosed EoE has
increasedmarkedly over the last 3 decades, whereas the prevalence
and incidence of EGE have not been fully clariﬁed. The prevalence of
EoE was calculated to be 17.1/100,000 in the Japanese population,10vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 2
Upper gastrointestinal symptoms.
Heart burn 62 (86.1%)
Bloating 63 (87.5%)
Feeling heavy after meals 65 (90.3%)
Subconsciously rubbing your chest 43 (60.9%)
Feeling sick after meals 21 (29.2%)
Heart burn after meals 20 (27.8%)
Unusual sensation in your throat 25 (34.7%)
Feeling full while eating meals 23 (31.9%)
Stucking when you swallow 25 (34.7%)
Bitter liquid coming up into your throat 61 (84.7%)
Burping a lot 62 (86.1%)
Heart burn when you bend over 18 (25.0%)
Epigastralgia 13 (18.1%)
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endoscopy-examined cases was recently reported in the USA to be
6.5%.12 EoE cases are frequently associated with allergic diseases
such as bronchial asthma (BA), atopic dermatitis, allergic rhinitis,
and various food or drug allergies. Approximately 30e50% of in-
dividuals with EoE have asthma, whereas only 10% of the general
population does.13,14 Similarly, 50e75% have allergic rhinitis, and
only 39% of healthy children do. In addition, 10e20% of children
with EoE have IgE-mediated food allergies (urticaria and anaphy-
laxis), whereas only 1e5% of normal children does.5,13,14 These rates
of atopy (asthma, allergic rhinitis, and atopic dermatitis) are
approximately three times higher than what is expected in the
general population. Also, approximately 30e50% of individuals
with EGE have allergic diseases like EoE.15,16
This study was to examine the eosinophil inﬁltration in the
upper gastrointestinal (GI) tract in patients with BA by using
esophagogastroduodenoscopy (EGD).
Methods
Ninety patients (36male and 54 female) with BAwho had upper
GI symptoms and underwent EGD in our hospital were enrolled in
this study. Patients treated with systemically administered steroids
were excluded, but those taking only inhaled steroids were not.
Their ages ranged from 16 to 78 years, and the mean age was 57.5
years. Eighty-one patients (90.0%) took inhaled corticosteroids, 14
(15.6%) took proton pump inhibitors, and 2 (2.2%) took H2 receptor
antagonists. Twenty-nine patients (32.2%) had allergic rhinitis, 8
(8.9%)hadatopicdermatitis, and5 (5.6%)had foodallergies (Table1).
Upper GI symptoms were examined using a frequency scale for
symptoms of gastroesophageal disease (F-scale).17 EGD was con-
ducted, and hiatal hernia was assessed using Makuuchi's classiﬁ-
cation18 and reﬂux esophagitis was assessed using the Los Angeles
classiﬁcation.19 A circular ring, longitudinal furrow, white exudate,
or stenosis in the esophagus was observed as a characteristic
ﬁnding in EoE. Moreover, edema, marked redness, erosion, or ulcer
in the stomach was observed as an endoscopic ﬁnding in EGE,
although those were not speciﬁc for EGE. Biopsy specimens were
taken at the upper, middle, and lower body of the esophagus and at
the gastric body and antrum and at the bulbus of the duodenum.
Eosinophilic inﬁltration was histologically diagnosed as more than
15 eosinophils in a high-power ﬁeld.
The study protocol was in accordance with the tenets of the
revised Declaration of Helsinki (1989) and was approved by the
institutional review boards at our institutions. Written informed
consent was obtained from all the patients. This study was regis-
tered with the UMIN Clinical Trials Registry (UMIN000010132).
Results
The questionnaire of upper GI symptoms was examined in 72
patients (80%).Table 1
Clinical characteristics of patients.
Male/Female 36/54
Mean age 57.5 (16e78)
Inpatients/Outpatients 6/84
Medication
Inhalant corticosteroids 81 (90.0%)
Proton pump inhibitor 14 (15.5%)
H2 receptor antagonist 2 (2.2%)
Allergic disease
Allergic rhinitis 29 (32.2%)
Atopic dermatitis 8 (8.9%)
Food allergy 5 (5.6%)Sixty-two patients (89.9%) had heartburn, 63 patients (87.5%)
had bloating, 65 patients (90.3%) had a heavy feeling aftermeals, 43
patients (59.7%) subconsciously rubbed their chest, 61 patients
(84.7%) had bitter liquid coming up into the throat, and 62 patients
(86.1%) had a lot of burping. Twenty-ﬁve patients (34.7%) had food
sticking when swallowing. Only thirteen patients (18.1%) had epi-
gastralgia (Table 2). The mean F-scale score was 9.0 (1e34), and 32
patients (44.4%) had an F-scale score greater than 8.
Eighty patients (88.9%) had hiatal hernia, 14 of whom had grade
A, 65 of whom had grade B, and one had grade C. Fourteen patients
(15.6%) had reﬂux esophagitis, 8 of whom had grade A and 6 of
whom had grade B, however, all had mild reﬂux esophagitis. A
circular ring, longitudinal furrow, white exudate, or stenosis in the
esophagus was not observed in any patient. Edema in the stomach
was observed in one patient, marked redness was observed in one
patient, and erosions were observed in one patient.
One patient, a 69-year-old female was diagnosed as having EGE
because she had severe epigastralgia, eosinophilia (1,825/mL) and
BA, whichwas treatedwith inhaled corticosteroids. EGD showed no
abnormal ﬁndings in the esophagus and the duodenum and
showed mild edema in the gastric antrum (Fig. 1). The pathological
ﬁndings in any location, however, showed eosinophil inﬁltration
(Fig. 2a, b). She has been improved by administration of oral
corticosteroids.
Another patient, a 16-year-old female who had precedent BA
that was treated with inhaled corticosteroids was diagnosed asFig. 1. Mild edema in the antrum.
Fig. 2. a: Eosinophil inﬁltration in the antral mucosa. b: Eosinophil inﬁltration in the
esophageal mucosa.
Fig. 3. a: No speciﬁc ﬁndings for EoE in the esophagus. b: Erosions in the antrum.
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because she had severe epigastralgia, marked eosinophilia (3,510/
mL), and a skin eruption. EGD showed no abnormal ﬁndings in the
esophagus (Fig. 3a) but showed erosions in the gastric antrum and
the duodenum (Fig. 3b). The pathological ﬁndings in any location
showed eosinophil inﬁltration (Fig. 4a, b). The pathological ﬁndings
of biopsy specimens of the skin eruption showed vasculitis in the
small arteries. She has been improved by administration of oral
corticosteroids.
Moreover, three patients with eosinophilic inﬁltration to the
stomach were detected, but EGD showed no abnormal ﬁndings in
the stomach, and all of them had no eosinophilia. They were not
diagnosed as having EGE because their upper GI symptoms were
mild and spontaneously improved thereafter.Discussion
Kusano et al.17 have reported that when the cutoff score was set
at 8 points, F-scale showed a sensitivity of 62%, a speciﬁcity of 59%,
and an accuracy of 60%. In our study, 32 of 72 patients with upper GI
symptoms (44.4%) had an F-scale score greater than 8. Most of themwere thought to have GERD. Eighty patients (88.8%) had hiatal
hernia regardless the level. Moreover, 14 patients (15.6%) had mild
reﬂux esophagitis. According to the Montreal deﬁnition and clas-
siﬁcation of GERD,20 BA is associated with GERD and it is one of the
extraesophageal syndromes caused by GERD. However, the symp-
toms of EoE are sometimes similar to those of GERD. Endoscopic
and pathological examinations are necessary for differentiation
between EoE and GERD.
Approximately 30e50% of individuals with EoE have BA.12 The
mechanisms of EoE might be similar to BA,21,22 but no patient with
EoE was detected among patients with BA in our study. Our study
had a small sample size and it was conducted in a single institution.
On the other hand, the standard treatment for BA is inhalation of
corticosteroids and severe BA is treated by systemic administration
of corticosteroids.23 Patients treated systemically administered
corticosteroids were excluded from our study, but those taking only
inhaled corticosteroids were not. In our study, most patients with
Fig. 4. a: Eosinophil inﬁltration in the esophageal mucosa. b: Eosinophil inﬁltration in the antral mucosa.
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steroid dose should be inhaled, but a bit of it might be swallowed.
The standard treatment for EoE is swallowing of inhaled cortico-
steroids in spite of coexistence of BA.1e5 Systematic administration
of corticosteroids is typically reserved when topical steroids are not
effective or patients need a rapid improvement in symptoms.24
Even if the amount of swallowed inhalant corticosteroids is small,
it might prevent the occurrence of EoE. Harer et al.25 have reported
that the use of inhaled corticosteroids was negatively associated
with EoE for asthma patients, and that one of the intriguing ﬁnd-
ings was the possible protective effect of inhaled steroids on having
EoE. This might be why no patients with EoE were observed in our
study. However, this incidental swallowing is unlikely to deliver the
level of steroid doses delivered directly to the esophageal mucosa
that are used to treat EoE.
In our study, the number of biopsy specimens in the esophagus
was three, but in the Western countries more than four biopsy
specimens from the mid and distal esophagus are recommended to
make a diagnosis of eosinophil inﬁltration in the esophagus.26
Eosinophil-predominant inﬂammation on esophageal biopsy
characteristically consists a peak value of more than 15 eosinophils
per high power ﬁeld.24 Eosinophil inﬁltration in the esophagus
could not be detected, because the number of biopsy specimens
might not be sufﬁcient.
Recently, it has been reported that some patients with symp-
toms suggestive of EoE have endoscopic features of EoE, however,
their symptoms and esophageal eosinophilia resolve after a PPI
course.27 It is now termed PPI-responsive esophageal eosinophilia.
It is not necessary to take inhaled corticosteroids if the patient's
symptoms are improved by PPI. The prevailing hypothesis to
explain PPI-responsive esophageal eosinophilia has been that
coexisting GERDmight be the priming event, allowing the potential
entry of food derived allergenic molecules through acid-induced
epithelial barrier damage. Thus, GERD-induced epithelial damage
could expose the deeper layers of the esophageal squamous
epithelium to antigens that ordinarily could not penetrate a normal
mucosa.28 In our study, 14 patients (15.6%) took PPI, therefore, PPI
might prevent EoE in those patients.
One patient who took inhalant corticosteroids was diagnosed
as having EGE. Eosinophil inﬁltration was detected not only in thestomach and duodenum but also in the esophagus. The inhalant
corticosteroids could not prevent the occurrence of EGE. The
clinical features of EGE are related to the location, extent, and
layer of bowel with eosinophil inﬁltration, and EGE has three
subtypes: mucosal disease, muscular-layer disease, and sub-
serosal disease.29 This patient had mucosal disease without as-
cites, but endoscopy showed only mild edema in the antrum.
Biopsy specimens are necessary to make a diagnosis of eosinophil
inﬁltration for those patients even if endoscopy does not show
abnormal ﬁndings.
EGPA, formerly named ChurgeStrauss syndrome is a rare sys-
temic small- and medium-sized vessel vasculitis, with severe BA
and blood and tissue eosinophilia. The classiﬁcation criteria include
4 out of 6; asthma, eosinophilia, history of allergy, pulmonary in-
ﬁltrates, paranasal abnormalities and extravascular eosinophils.
Approximately 30e50% of patients with EGPA have been reported
to have involvement of the gut.30 In our study, one patient who took
inhalant corticosteroids was diagnosed as having EGPA. Eosinophil
inﬁltration was detected not only in the stomach and duodenum
but also in the esophagus. The inhalant corticosteroids could not
prevent the occurrence of EGPA. Endoscopy showed mild erosions
in the antrum and duodenum. Biopsy specimens are necessary to
make a diagnosis of eosinophil inﬁltration for those patients.
Three patients with eosinophil inﬁltration in the stomach were
detected but they were not diagnosed as having EGE because their
upper GI symptoms were mild and improved thereafter. The
eosinophil inﬁltration in the stomach might be spontaneous and
temporary due to food allergies. Follow-up examination is needed.
There are some limitations in this study. As the sample size was
too small, a large multicenter trial is expected in near future. Pa-
tients treated not only systemically administered corticosteroids
but also inhaled corticosteroids are needed to be excluded. How-
ever, it seems to be difﬁcult to enroll those patients. The number of
appropriate biopsy specimens in the esophagus must be
determined.
In conclusion, patients with asthma who had upper gastroin-
testinal symptoms rarely had eosinophilic gastrointestinal disor-
ders. Biopsy specimens are of high importance in the diagnosis of
eosinophilic gastrointestinal disorders even if there is no remark-
able endoscopic ﬁnding.
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